ZA915462B - Composition for the treatment of alzheimer's disease and process for preparing the same - Google Patents

Composition for the treatment of alzheimer's disease and process for preparing the same

Info

Publication number
ZA915462B
ZA915462B ZA915462A ZA915462A ZA915462B ZA 915462 B ZA915462 B ZA 915462B ZA 915462 A ZA915462 A ZA 915462A ZA 915462 A ZA915462 A ZA 915462A ZA 915462 B ZA915462 B ZA 915462B
Authority
ZA
South Africa
Prior art keywords
alzheimer
disease
preparing
treatment
composition
Prior art date
Application number
ZA915462A
Other languages
English (en)
Inventor
E Szilveszter Vizi
Szilveszter Vizi E
Jeno Szilbereky
Szilbereky Jeno
Peter Literati Nagy
Literati Nagy Peter
Original Assignee
Biorex Kutato Fejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejleszto Kft filed Critical Biorex Kutato Fejleszto Kft
Publication of ZA915462B publication Critical patent/ZA915462B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA915462A 1990-07-12 1991-07-12 Composition for the treatment of alzheimer's disease and process for preparing the same ZA915462B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU904191A HU207444B (en) 1990-07-12 1990-07-12 Method for producing therapeutical preparation suitable for treating alzheimer-disease

Publications (1)

Publication Number Publication Date
ZA915462B true ZA915462B (en) 1992-04-29

Family

ID=10967276

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915462A ZA915462B (en) 1990-07-12 1991-07-12 Composition for the treatment of alzheimer's disease and process for preparing the same

Country Status (8)

Country Link
EP (1) EP0607125A1 (xx)
JP (1) JPH05508843A (xx)
AU (1) AU645826B2 (xx)
CZ (1) CZ280474B6 (xx)
HU (1) HU207444B (xx)
IE (1) IE912431A1 (xx)
WO (1) WO1992000737A1 (xx)
ZA (1) ZA915462B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730463B1 (de) * 1993-11-26 2000-02-02 Karla Lehmann Verwendung von lithiumverbindungen zur behandlung und prophylaxe des morbus alzheimer
IL138192A0 (en) 1998-03-11 2001-11-25 Smithkline Beecham Plc Controlled release oral dosage forms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
JPH05508843A (ja) 1993-12-09
HU904191D0 (en) 1990-12-28
WO1992000737A1 (en) 1992-01-23
IE912431A1 (en) 1992-01-15
AU645826B2 (en) 1994-01-27
AU8205391A (en) 1992-02-04
HUT58519A (en) 1992-03-30
CZ280474B6 (cs) 1996-01-17
EP0607125A1 (en) 1994-07-27
HU207444B (en) 1993-04-28
CS216591A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
EP0541686A4 (en) Tachykinin agonists for treatment of alzheimer's disease
IL106877A0 (en) Compounds useful as hypoglycemic agents and for treating alzheimer's disease
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
HUT62559A (en) Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same
CS44191A3 (en) Derivative of 1-pyridylimidazole and process for preparing and use thereof
GB2223026B (en) Compositions and process for the treatment of textiles
ZA829335B (en) Pharmaceutical preparation for treating alzheimer's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
AU4759390A (en) Method of medical treatment of alzheimer's disease
GB2225787B (en) Compositions and process for the treatment of textiles
EP0389110A3 (en) Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
ZA914435B (en) Treatment of disease
ZA915462B (en) Composition for the treatment of alzheimer's disease and process for preparing the same
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
EP0486584A4 (en) Dopaminergic neurotrophic factor for treatment of parkinson's disease
HU912403D0 (en) Process for the production of medical preparations for treating allergic conjunctivitis
HU911086D0 (en) Process for the production and use of 2-dezoxy-d-treo-pentofluoranozides and intermediers thereof
HU907632D0 (en) Process for producing tetra-o-acetyl-d-o-glycosides of 4'-desmethyl-4'-alkoxy-carbonyl-epidophyllotoxines
EP0457725A3 (en) Process for the preparation of 2,3-dibromopropionyl chloride
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
GB8902941D0 (en) Compositions and process for the treatment of textiles